News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Yi Kathy
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/13/2022 |
4
| Yi Kathy (Director) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options to buy
@ $5.75, valued at
$172.5k
|
|
| 10/08/2021 |
4
| Yi Kathy (Director) has filed a Form 4 on Theseus Pharmaceuticals, Inc.|
Txns:
| Granted 22,678 options to buy
@ $16, valued at
$362.8k
|
|
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/30/2020 |
4
| Yi Kathy (CFO) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.|
Txns:
| Granted 78,534 options to buy
@ $9.88, valued at
$775.9k
|
|
| 05/17/2019 |
4
| Yi Kathy (EVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $10, valued at
$50k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 04/16/2019 |
4
| Yi Kathy (EVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $12.11, valued at
$60.6k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 03/18/2019 |
4
| Yi Kathy (EVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $10, valued at
$50k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 03/05/2019 |
4
| Yi Kathy (EVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $10, valued at
$50k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 02/27/2019 |
4
| Yi Kathy (EVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 19,250 shares
@ $0
Granted 115,500 options to buy
@ $9.03, valued at
$1M
|
|
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/16/2019 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $11.04, valued at
$55.2k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 12/18/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $11.44, valued at
$57.2k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 11/16/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $10, valued at
$50k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/18/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $14.6569, valued at
$73.3k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 08/17/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $15.3903, valued at
$77k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 07/17/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $14.772, valued at
$73.9k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 06/15/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $15.673, valued at
$78.4k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $19.8288, valued at
$99.1k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 03/16/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Sold 5,000 shares
@ $25.5624, valued at
$127.8k
Exercised 5,000 options to buy
@ $4.55, valued at
$22.8k
|
|
| 01/31/2018 |
4
| Yi Kathy (SVP & CFO) has filed a Form 4 on SANGAMO THERAPEUTICS, INC|
Txns:
| Granted 7,250 shares
@ $0
Granted 43,500 options to buy
@ $20.05, valued at
$872.2k
|
|
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|